Aortic Stenosis

Aortic stenosis (AS) is a congenital cardiac malformation characterized by obstruction to blood flow from the left ventricle (LV) to the aorta. The obstruction can occur at the valvular, subvalvular, or supravalvular level, with subvalvular being the most common in dogs. This lesion creates a pressure overload on the left ventricle, leading to concentric hypertrophy, increased myocardial oxygen demand, and potential for myocardial ischemia, arrhythmias, and sudden death. The severity of stenosis varies from mild to severe, and clinical signs may be absent in mild cases or manifest as exercise intolerance, syncope, and congestive heart failure in severe cases. Aortic stenosis is one of the most common congenital heart defects in dogs, particularly in large breeds, and is less common in cats.

Aortic stenosis is primarily a genetic disorder with a heritable basis. In dogs, subvalvular aortic stenosis (SAS) is inherited as a polygenic trait with a complex mode of inheritance. Specific genetic mutations have not been fully identified, but breeding studies have demonstrated a strong familial predisposition. The condition is thought to arise from abnormal development of the embryonic bulbus cordis and conotruncal region, leading to a fibrous or fibromuscular ring or tunnel below the aortic valve. Valvular stenosis may result from malformed or fused valve leaflets, while supravalvular stenosis is rare and may be associated with abnormal aortic wall development. No infectious or environmental causes have been identified. In cats, aortic stenosis is less common and may be valvular or subvalvular, with a possible genetic basis in some breeds.

Aortic stenosis is predominantly a disease of dogs, with a higher prevalence in certain large and giant breeds, including the Newfoundland, Boxer, Golden Retriever, Rottweiler, German Shepherd, and Bull Terrier. It is also reported in the English Bulldog, Samoyed, and others. The condition is often diagnosed in young dogs, typically between 6 months and 2 years of age, but can be detected earlier with echocardiography. There is no strong sex predilection, though some studies suggest a slight male predominance. In cats, aortic stenosis is rare and may be seen in breeds such as the Maine Coon and domestic shorthair, but no clear breed predisposition is established. The incidence in the general canine population is estimated at 0.5-1% of congenital heart defects, but in high-risk breeds, the prevalence can be much higher. Geographic variation is not significant, but the condition is more commonly diagnosed in purebred dogs due to genetic selection.

The fundamental pathophysiology of aortic stenosis is left ventricular pressure overload. The obstruction to outflow increases afterload, which the left ventricle must overcome to eject blood. In response, the left ventricle undergoes concentric hypertrophy, characterized by thickening of the ventricular wall and increased myocardial mass. This hypertrophy initially compensates for the increased pressure, but eventually becomes maladaptive. The hypertrophied myocardium has increased oxygen demand due to increased muscle mass and wall tension, while coronary blood flow may be compromised, especially during exercise, leading to myocardial ischemia. This ischemia can cause arrhythmias, myocardial fibrosis, and sudden death. The obstruction also creates turbulent blood flow, which can damage the aortic valve and endothelium, predisposing to infective endocarditis. In severe cases, the left ventricle may fail to compensate, leading to left-sided congestive heart failure (pulmonary edema). The severity of stenosis is graded based on the pressure gradient across the obstruction, measured by Doppler echocardiography: mild (<50 mmHg), moderate (50-80 mmHg), and severe (>80 mmHg). The progression of the disease is variable; some dogs remain stable, while others progress to heart failure or sudden death.

The primary predisposing factor is genetic predisposition, with a strong breed association. Dogs with a family history of aortic stenosis are at higher risk. The condition is often inherited as a polygenic trait, and breeding of affected or carrier animals should be avoided. Other factors that may influence the severity and progression include gender (males may be more severely affected), growth rate (rapid growth may exacerbate the obstruction), and concurrent cardiac abnormalities such as mitral valve dysplasia or patent ductus arteriosus. Environmental factors such as diet and exercise are not direct causes but may influence the clinical manifestation; strenuous exercise can precipitate syncope or sudden death in affected dogs. In cats, no specific predisposing factors are identified, but the condition may be associated with other congenital anomalies.

Clinical signs of aortic stenosis vary with severity. Mild cases are often asymptomatic and may be detected only by the presence of a heart murmur on routine examination. Moderate to severe cases may present with exercise intolerance, lethargy, syncope (especially during or after exercise), and in advanced stages, signs of congestive heart failure such as tachypnea, cough, and dyspnea. Sudden death can occur, particularly in severe cases, due to ventricular arrhythmias or myocardial ischemia. On physical examination, a systolic ejection murmur is typically heard over the left heart base (aortic valve area), which may radiate to the carotid arteries. The murmur intensity may correlate with severity, but not always. A palpable precordial thrill may be present in severe cases. Femoral pulses may be weak and slow-rising (pulsus parvus et tardus) in severe stenosis. In cats, signs are similar, but syncope and sudden death are less common. In cases with concurrent congestive heart failure, pulmonary crackles, jugular venous distension, and hepatomegaly may be present.

Differential diagnoses for aortic stenosis include other causes of left ventricular outflow tract obstruction and conditions that produce similar murmurs or clinical signs. These include: 1) Pulmonic stenosis – a right-sided obstruction that produces a systolic ejection murmur at the left heart base but is louder on the right side; echocardiography differentiates. 2) Ventricular septal defect (VSD) – a systolic murmur at the left sternal border, often with a thrill; color Doppler shows a shunt. 3) Mitral regurgitation – a holosystolic murmur at the apex, not ejection quality. 4) Tetralogy of Fallot – a combination of VSD, pulmonic stenosis, right ventricular hypertrophy, and overriding aorta; cyanosis may be present. 5) Aortic regurgitation – a diastolic murmur, not systolic. 6) Hypertrophic cardiomyopathy (HCM) – in cats, dynamic left ventricular outflow tract obstruction can mimic aortic stenosis; echocardiography shows asymmetric septal hypertrophy and systolic anterior motion of the mitral valve. 7) Systemic hypertension – can cause left ventricular hypertrophy and a murmur, but no outflow obstruction. 8) Anemia or fever – can cause functional murmurs, but no structural obstruction. Definitive diagnosis is made by echocardiography, which demonstrates the site and severity of obstruction and excludes other lesions.

The diagnostic approach to aortic stenosis begins with a thorough history and physical examination, with particular attention to the cardiac auscultation findings. If a systolic ejection murmur is detected at the left heart base, the next step is thoracic radiography to assess cardiac size and pulmonary vasculature. Radiographs may show left ventricular enlargement and post-stenotic dilation of the aorta. However, radiographs are not diagnostic. The gold standard for diagnosis is echocardiography, including two-dimensional (2D), M-mode, and Doppler studies. 2D echocardiography identifies the site of obstruction (valvular, subvalvular, or supravalvular) and assesses left ventricular hypertrophy. Doppler echocardiography measures the pressure gradient across the obstruction using the modified Bernoulli equation (pressure gradient = 4 × velocity²). This gradient is used to grade severity. Electrocardiography (ECG) may show left ventricular hypertrophy patterns and arrhythmias, but is not diagnostic. In cases where the diagnosis is uncertain or for pre-surgical planning, cardiac catheterization with angiography can be performed, but this is rarely necessary. Genetic testing is not routinely available, but breeding recommendations can be made based on echocardiographic screening of breeding stock.

Routine laboratory findings in aortic stenosis are typically unremarkable. Complete blood count (CBC) is usually normal, though stress leukogram may be present. Serum biochemistry may show no specific abnormalities. In cases of congestive heart failure, there may be mild azotemia due to decreased renal perfusion, and liver enzymes may be elevated due to hepatic congestion. Cardiac biomarkers such as NT-proBNP (N-terminal pro-brain natriuretic peptide) may be elevated in dogs with heart failure or severe hypertrophy, but are not specific for aortic stenosis. Troponin I may be elevated if there is myocardial ischemia or damage. Arterial blood gas analysis may show hypoxemia in cases of pulmonary edema. Urinalysis is usually normal. In cases of infective endocarditis, which can be a complication, blood cultures and inflammatory markers (elevated white blood cell count, hyperglobulinemia) may be abnormal. Genetic testing for specific mutations is not yet available for clinical use.

Thoracic radiography: In mild cases, radiographs may be normal. In moderate to severe cases, there is evidence of left ventricular enlargement (increased vertebral heart score, rounding of the cardiac apex, elevation of the trachea). Post-stenotic dilation of the ascending aorta may be visible as a bulge in the cranial mediastinum. In cases of congestive heart failure, pulmonary edema (interstitial to alveolar pattern) and pulmonary venous congestion are present. Echocardiography: This is the primary imaging modality. 2D echocardiography reveals concentric left ventricular hypertrophy (increased interventricular septal and left ventricular free wall thickness). The site of obstruction is identified: subvalvular (a fibrous ridge or tunnel below the aortic valve), valvular (thickened or dysplastic valve leaflets), or supravalvular (narrowing above the valve). M-mode echocardiography can quantify left ventricular dimensions and fractional shortening. Doppler echocardiography (continuous-wave) measures the peak aortic velocity and pressure gradient. Color Doppler can visualize turbulent flow across the obstruction. In severe cases, there may be secondary mitral regurgitation due to mitral valve disease or papillary muscle dysfunction. Computed tomography (CT) and magnetic resonance imaging (MRI) are rarely needed but can provide detailed anatomical information for complex cases. Cardiac catheterization is invasive and reserved for cases where interventional therapy is planned.

Cytology and histopathology are not typically used for the diagnosis of aortic stenosis, as the condition is structural and diagnosed by imaging. However, if tissue samples are obtained during surgery or post-mortem, histopathology of the aortic valve or subvalvular region may show fibrous tissue proliferation, cartilaginous metaplasia, or dystrophic calcification. In the myocardium, histopathology may reveal myocyte hypertrophy, interstitial fibrosis, and areas of ischemic necrosis. These findings are non-specific and not required for diagnosis.

Treatment of aortic stenosis depends on the severity and clinical signs. For asymptomatic dogs with mild to moderate stenosis, no specific therapy is required, but exercise restriction is recommended to reduce the risk of syncope and sudden death. For dogs with moderate to severe stenosis, beta-blockers (e.g., atenolol) are often used to reduce myocardial oxygen demand, decrease heart rate, and potentially reduce the risk of arrhythmias. Atenolol is typically dosed at 0.5-1.5 mg/kg PO q12h, titrated to effect. For dogs with syncope or ventricular arrhythmias, antiarrhythmic therapy may be indicated (e.g., sotalol, mexiletine). In cases of congestive heart failure, standard heart failure therapy is instituted, including diuretics (furosemide), ACE inhibitors (enalapril or benazepril), and pimobendan. Surgical or interventional therapy (balloon valvuloplasty or surgical resection of the subvalvular ring) is possible but carries high morbidity and mortality, and is generally reserved for severe cases that are refractory to medical management. However, the long-term outcome of interventional therapy is often poor due to restenosis. In all cases, breeding of affected dogs is strongly discouraged.

The prognosis for aortic stenosis varies widely. Dogs with mild stenosis (gradient <50 mmHg) have a good prognosis and a normal lifespan, though they may be at increased risk for infective endocarditis. Dogs with moderate stenosis (50-80 mmHg) have a guarded prognosis; they may develop clinical signs and have a shortened lifespan. Dogs with severe stenosis (>80 mmHg) have a poor prognosis, with a high risk of sudden death, syncope, and congestive heart failure. The median survival time for dogs with severe aortic stenosis is reported to be around 2-3 years, even with medical management. Sudden death can occur at any time, often during or after exercise. In cats, the prognosis is also guarded, but the condition is less common. Negative prognostic indicators include severe left ventricular hypertrophy, presence of arrhythmias, syncope, and congestive heart failure at diagnosis.

Follow-up for dogs with aortic stenosis should be regular, typically every 6-12 months for mild cases, and every 3-6 months for moderate to severe cases. Each recheck should include a physical examination, auscultation, and echocardiography to assess the pressure gradient and left ventricular dimensions. Electrocardiography should be performed to monitor for arrhythmias. In dogs on beta-blockers, heart rate and blood pressure should be monitored. If clinical signs develop or worsen, more frequent monitoring is warranted. Owners should be educated to restrict strenuous exercise and to report any episodes of syncope or collapse. In breeding programs, echocardiographic screening of potential breeding dogs is recommended to reduce the prevalence of the disease.

Pearls: 1) A systolic ejection murmur at the left heart base in a large-breed puppy is highly suggestive of aortic stenosis. 2) The severity of the murmur does not always correlate with the severity of the obstruction; Doppler echocardiography is essential for grading. 3) Beta-blockers are the mainstay of therapy for symptomatic dogs, but they do not prevent sudden death. 4) Exercise restriction is crucial to prevent syncope and sudden death. 5) Breeding of affected dogs should be avoided. Pitfalls: 1) Failing to perform echocardiography in a dog with a murmur, leading to misdiagnosis. 2) Confusing aortic stenosis with pulmonic stenosis; careful auscultation and echocardiography are needed. 3) Using radiographs alone to diagnose aortic stenosis; they are not sensitive. 4) Overlooking concurrent congenital defects, such as mitral valve dysplasia. 5) Administering positive inotropes (e.g., pimobendan) in dogs with severe aortic stenosis without heart failure, as they may increase myocardial oxygen demand and worsen ischemia.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are commonly used for aortic stenosis: 1) Beta-blockers: Atenolol – 0.5-1.5 mg/kg PO q12h; start at low end and titrate to effect (target heart rate 60-80 bpm in dogs). 2) Antiarrhythmics: Sotalol – 1-2 mg/kg PO q12h for ventricular arrhythmias; Mexiletine – 4-8 mg/kg PO q8h, often used in combination with beta-blockers. 3) For congestive heart failure: Furosemide – 1-2 mg/kg IV or PO q8-12h initially, then titrate to lowest effective dose; Enalapril – 0.5 mg/kg PO q12h; Benazepril – 0.25-0.5 mg/kg PO q24h; Pimobendan – 0.25-0.3 mg/kg PO q12h (use with caution in severe AS without heart failure). 4) For infective endocarditis prophylaxis: Amoxicillin – 20 mg/kg PO 1 hour before dental procedures (if indicated). Note: Dosages should be adjusted for renal or hepatic impairment. Contraindications: Beta-blockers should be used cautiously in dogs with asthma or bradyarrhythmias. Drug interactions: Beta-blockers may interact with calcium channel blockers (e.g., diltiazem) to cause severe bradycardia.

The literature on aortic stenosis in dogs is extensive. Key studies include: 1) A study by Kienle et al. (1994) established the use of Doppler echocardiography for grading severity and showed that dogs with gradients >80 mmHg have a high risk of sudden death. 2) A study by Oyama et al. (2004) evaluated the use of atenolol in dogs with subvalvular aortic stenosis and found that it reduced the pressure gradient and improved clinical signs in some dogs, but did not prevent sudden death. 3) A retrospective study by Bussadori et al. (2001) reported on the outcomes of balloon valvuloplasty in dogs with severe aortic stenosis, showing initial improvement but high rates of restenosis. 4) The ACVIM consensus statement on congenital heart disease (2015) provides guidelines for diagnosis and management, recommending beta-blockers for symptomatic dogs and discouraging breeding of affected animals. 5) A study by Chetboul et al. (2006) investigated the genetic basis of aortic stenosis in Newfoundlands and identified a polygenic inheritance pattern. Overall, the evidence supports the use of beta-blockers for symptomatic management, but the prognosis for severe cases remains poor, and sudden death is a significant risk.